SWK Holdings Corp (SWKHL) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$25.14

From 52W high−3.01%

Volume5666.00

Market cap$304.50M

P/E (TTM)—

P/S (TTM)7.3x

Div yield6.72%

Key dataOct 19, 2026

Open

$25.14

From 52W high

−3.01%

Volume

5666.00

Market cap

$304.50M

ValuationView details →

P/E (Fwd)

47.9x

EV/EBITDA

16.6x

P/E (TTM)

—

RSI (14)

47.1

MomentumView details →

1D Return

−0.06%

YTD Return

−1.37%

SummaryUpdated Dec 1, 2025

SWK Holdings Corporation (NASDAQ:SWKH) is a specialty finance company founded in 1996 and headquartered in Dallas, Texas. Originally incorporated as Kana Software, Inc., the company underwent a significant transformation and changed its name to SWK Holdings Corporation in December 2009. Today, SWK operates as a focused healthcare finance provider, having evolved from its software origins into a specialized lender serving the life sciences sector. The company has simplified its business model in recent years, transitioning from a diversified approach to concentrate primarily on providing customized financing solutions to biotechnology, medical device, pharmaceutical, and related healthcare companies.

Ask drillr about SWK Holdings Corp →

ValuationView details →

P/E (Fwd)

47.9x

P/E (TTM)

—

EV/EBITDA

16.6x

EV/Sales

7.1x

P/S (TTM)

7.3x

P/B (TTM)

1.3x

ProfitabilityView details →

Gross Margin

0.00%

Net Margin

−6.11%

EBITDA Margin

42.63%

ROE (TTM)

−1.08%

ROA (TTM)

−0.93%

Asset Turnover

0.15x

GrowthView details →

Revenue YoY

−7.85%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−0.02%

EPS CAGR 3Y

—

EBITDA YoY

−28.94%

MomentumView details →

1D Return

−0.06%

YTD Return

−1.37%

1Y Return

−1.37%

RSI (14)

47.1

vs 50D SMA

−0.54%

vs 200D SMA

−1.12%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

9.41x

Quick Ratio

9.41x

Div Yield

6.72%

Div Rate

$1.69

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.59

EPS Surprise

−402.86%

Beats (12Q)

1/12

Next Q EPS Est

$0.52

Avg Surprise (4Q)

−145.34%

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

41.46M

Net Income (TTM)

−2.53M

Op. CF (TTM)

35.99M

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for SWKHL.

Similar companies

Oaktree Acquisition Corp. III Life Sciences UnitOACCU Great Elm Capital Corp. 7.75% Notes Due 2030GECCG OTG Acquisition Corp. I Class A Ordinary ShareOTGA Janus Henderson International Div NHDRVX Great Elm Capital Corp. - 8.125GECCH GSR IV Acquisition Corp. Class A ordinary shareGSRF Find similar companies →

Latest newsMore news →

No recent news for SWKHL.